Cite
HARVARD Citation
Kitahara, H. et al. (n.d.). Eribulin differentiates cetuximab resistant oral squamous cell carcinoma cells to sensitive by inducing mesenchymal–epithelial transition (MET). European journal of cancer. pp. S54-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kitahara, H. et al. (n.d.). Eribulin differentiates cetuximab resistant oral squamous cell carcinoma cells to sensitive by inducing mesenchymal–epithelial transition (MET). European journal of cancer. pp. S54-. [Online].